BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9092561)

  • 1. The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells.
    Baltensperger K; Porzig H
    J Biol Chem; 1997 Apr; 272(15):10151-9. PubMed ID: 9092561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular nucleotides act through P2U purinoceptors to elevate [Ca2+]i and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes.
    Kaplan AD; Kilkenny DM; Hill DJ; Dixon SJ
    Endocrinology; 1996 Nov; 137(11):4757-66. PubMed ID: 8895344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2-purinoceptor-mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells.
    Strøbaek D; Olesen SP; Christophersen P; Dissing S
    Br J Pharmacol; 1996 Aug; 118(7):1645-52. PubMed ID: 8842427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
    Ho C; Hicks J; Salter MW
    Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y and P2U receptors differentially release intracellular Ca2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord.
    Idestrup CP; Salter MW
    Neuroscience; 1998 Oct; 86(3):913-23. PubMed ID: 9692727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2U receptor is linked to cytosolic Ca2+ transient and release of vasorelaxing factor in bovine endothelial cells in situ.
    Miyagi Y; Kobayashi S; Nishimura J; Fukui M; Kanaide H
    J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):751-61. PubMed ID: 8734987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways.
    Schwaner I; Seifert R; Schultz G
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):301-7. PubMed ID: 1310589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct P2 purinergic receptors, P2Y and P2U, are coupled to phospholipase C in mouse pineal gland tumor cells.
    Suh BC; Son JH; Joh TH; Kim KT
    J Neurochem; 1997 Apr; 68(4):1622-32. PubMed ID: 9084434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y purinoceptor activation mobilizes intracellular Ca2+ and induces a membrane current in rat intracardiac neurones.
    Liu DM; Katnik C; Stafford M; Adams DJ
    J Physiol; 2000 Jul; 526 Pt 2(Pt 2):287-98. PubMed ID: 10896718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2 purinoceptors in cultured bovine middle cerebral artery endothelial cells.
    Zhang H; Weir BK; Marton LS; Lee KS; Macdonald RL
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):767-74. PubMed ID: 9436816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of signaling pathways of P2Y and P2U purinoceptors in bovine pulmonary artery endothelial cells.
    Chen BC; Lee CM; Lee YT; Lin WW
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):192-9. PubMed ID: 8856473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
    Shi XP; Yin KC; Gardell SJ
    Thromb Res; 1995 Feb; 77(3):235-47. PubMed ID: 7740516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
    Mateo J; Miras-Portugal MT; Castro E
    Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression cloning and signal transduction pathway of P2U receptor in mammary tumor cells.
    Enomoto K; Furuya K; Moore RC; Yamagishi S; Oka T; Maeno T
    Biol Signals; 1996; 5(1):9-21. PubMed ID: 8739319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of P2 purinoceptor agonists on membrane potential and intracellular Ca2+ of human cardiac endothelial cells.
    Zünkler BJ; Gräfe M; Henning B; Kühne S; Ott T; Fleck E; Hildebrandt AG
    Pharmacol Toxicol; 1999 Jul; 85(1):7-15. PubMed ID: 10426157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of Ca2(+)-handling following nicotinic acetylcholine receptor stimulation, P2U-purinoceptor stimulation and K(+)-induced depolarization in C2C12 myotubes.
    Henning RH; Duin M; van Popta JP; Nelemans A; den Hertog A
    Br J Pharmacol; 1996 Apr; 117(8):1785-91. PubMed ID: 8732292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2u purinoceptor modulation of intracellular Ca2+ in a human lung adenocarcinoma cell line: down-regulation of Ca2+ influx by protein kinase C.
    Clunes MT; Kemp PJ
    Cell Calcium; 1996 Oct; 20(4):339-46. PubMed ID: 8939353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies.
    King BF; Neary JT; Zhu Q; Wang S; Norenberg MD; Burnstock G
    Neuroscience; 1996 Oct; 74(4):1187-96. PubMed ID: 8895885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-induced calcium mobilization in glomerular mesangial cells is mediated by P2U purinoceptor.
    Takeda M; Kawamura T; Kobayashi M; Endou H
    Biochem Mol Biol Int; 1996 Aug; 39(6):1193-200. PubMed ID: 8876973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells.
    Wiley JS; Chen JR; Jamieson GP; Thurlow PJ
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):589-94. PubMed ID: 7487900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.